GOLDMAN SACHS GROUP INC - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C100. A total of 40 filers reported holding CORMEDIX INC in Q3 2016. The put-call ratio across all filers is 8.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORMEDIX INC
ValueSharesWeighting
Q4 2016$65,000
-72.7%
42,501
-54.9%
0.00%
Q3 2016$238,000
+49.7%
94,217
+18.2%
0.00%
Q2 2016$159,000
+18.7%
79,692
+57.7%
0.00%
Q1 2016$134,000
+91.4%
50,531
+45.3%
0.00%
Q3 2015$70,000
-73.7%
34,788
-49.3%
0.00%
Q2 2015$266,000
+10.8%
68,679
+181.6%
0.00%
Q1 2015$240,000
+990.9%
24,388
+115.2%
0.00%
Q4 2014$22,000
+4.8%
11,335
-0.4%
0.00%
Q3 2014$21,000
+10.5%
11,377
+8.5%
0.00%
Q2 2014$19,000
-56.8%
10,485
-39.7%
0.00%
Q1 2014$44,00017,4000.00%
Other shareholders
CORMEDIX INC shareholders Q3 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 42,400$22,0000.05%
SABBY MANAGEMENT, LLC 648,955$337,0000.02%
ELLIOTT MANAGEMENT CORP 4,166,868$2,167,0000.01%
Bollard Group LLC 401,920$209,0000.01%
RAY GERALD L & ASSOCIATES LTD 57,000$30,0000.00%
Virtu Financial LLC 100,138$52,0000.00%
Steward Partners Investment Advisory, LLC 48,590$25,0000.00%
Ahrens Investment Partners LLC 10,000$5,0000.00%
THOMPSON DAVIS & CO., INC. 2,000$1,0000.00%
TAURUS ASSET MANAGEMENT, LLC 30,000$16,0000.00%
View complete list of CORMEDIX INC shareholders